N-substituted tricyclic 1-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders
US7795440B2 · kind B2 · utility
0Cited by
16References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 25, 2007 |
| Grant date | Sep 14, 2010 |
| Priority date | — |
| Expiry date | Aug 22, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention is directed to N-substituted tricyclic 3-AMINOPYRAZOLE derivatives, which are useful as inhibitors of platelet-derived growth factor receptor (PDGF-R) kinase, and methods for the preparation of said derivatives. The present invention is further directed to pharmaceutical compositions comprising the compounds of the present invention and to methods for treating conditions such as tumors and other cell proliferative disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.